CD8A and cancer: Overall, the ability of DCs to capture and present antigens is enhanced, and their ability to process NM-neoAgs and recruit CD4+ T cells/CD8+ T cells for an enhanced adaptive immune response in the tumor is more effective, thereby enhancing the immune system’s ability to clear cancer cells (66).